Efficacy News and Research

RSS

The T2B Infrastructure Center for Respiratory Disease set to enter into the final phase

The Korea Institute of Toxicology (KIT·Chief Dr. Song, Chang-woo) National Center for Efficacy Evaluation of Respiratory Disease Product (NCER·Chief Dr. Lee, Kyu-hong) obtained on January 10 the final decision from the Ministry of Health and Welfare that the T2B Infrastructure Center for Respiratory Disease would enter into the final phase (second phase) with funding of 3 billion KRW over two years.

4 Feb 2019

UC study reveals most effective medication for treating pediatric anxiety

Researchers from the University of Cincinnati (UC) examined common medications prescribed for children and adolescents with anxiety disorders, to determine which are the most effective and best-tolerated.

1 Feb 2019

Tropoelastin protein accelerates growth of stem cells

Stem cells are vital for therapeutic treatments to repair and build human tissue including skin and muscles. Researchers are constantly looking for ways to make stem cells work better, with worldwide demand for the cells far outstripping supply.

1 Feb 2019

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

New method predicts how drug molecules arrange themselves under changing energetic conditions

One major factor that determines the efficacy of a drug is the structure that its molecules form in a solid state.

1 Feb 2019

Homeopathy Reconsidered: A factual book reappraises long-standing debate

Opinions on homeopathy are, and have always been, highly polarized: Avowed opponents face enthusiastic proponents - and their views are mostly incompatible.

1 Feb 2019

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.

1 Feb 2019

Cultural practices improve health of Indigenous women recovering from trauma of partner violence

The health of Indigenous women recovering from the trauma of partner violence improves when the healing process integrates elder-led circles and other cultural elements, finds new research from the University of British Columbia and Western University.

31 Jan 2019

New apprenticeship scheme set to support Life Sciences Industrial Strategy of the UK government

Approval has been granted for the development of a new national apprenticeship standard for the role of clinical pharmacology scientist, thanks to a cross-sector drive to address the skills gap.

31 Jan 2019

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

Although Huntington's disease (HD) is traditionally thought of as a neurological disorder, behavioral symptoms are a common feature and frequently cause distress and difficulty to patients, family members, and other caregivers.

30 Jan 2019

E-cigarettes are almost twice as effective as nicotine replacement treatments, shows new study

E-cigarettes are almost twice as effective as nicotine replacement treatments, such as patches and gum, at helping smokers to quit, according to a clinical trial led by Queen Mary University of London.

30 Jan 2019

Vaccination with live S. mitis may offer protection from Streptococcus pneumoniae

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice.

30 Jan 2019

Computational model of the heart’s mitral valve enables customized care for patients

Engineers at The University of Texas at Austin have developed a new noninvasive technique for simulating repairs to the heart's mitral valve with levels of accuracy reliable enough for use in a clinical setting.

30 Jan 2019

Expediting HPLC Method Development in Pharmaceutical Analysis

In this interview, Michael Dong discusses stability-indicating methods such as UHPLC, in pharmaceutical analysis. At Pittcon, Michael will introduce a 3-pronged template approach to HPLC method development.

From Pittcon 30 Jan 2019

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

Corning Incorporated will showcase advanced 3D cell culture technologies and workflow solutions, and including those for high throughput screening and ADME/toxicology at SLAS 2019.

From Corning Life Sciences 30 Jan 2019

Having vaccine after shingles appear do not reduce the risk of stroke

Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

30 Jan 2019

Sleep, mood, and stress affect older adults' control beliefs

Psychology researchers have found another reason that sleep, mood and stress are important: they affect the extent to which older adults feel they have control over their lives.

29 Jan 2019

First precision medicine trial in lung cancer expands to include more patients

The Lung Cancer Master Protocol, the first precision medicine trial in lung cancer supported by the National Cancer Institute, part of the National Institutes of Health, is undergoing a major expansion to include patients with all non-small cell lung cancers -- which make up about 85 percent of all lung cancer diagnoses in the U.S.

29 Jan 2019

Researchers compare treatment options for fecal incontinence

It is a common health problem that causes uncommon personal discomfort. Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence.

29 Jan 2019

Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer

A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer.

29 Jan 2019

Efficacy News and Research

The T2B Infrastructure Center for Respiratory Disease set to enter into the final phase

UC study reveals most effective medication for treating pediatric anxiety

Tropoelastin protein accelerates growth of stem cells

Newron announces successful completion of patient enrollment in STARS study

New method predicts how drug molecules arrange themselves under changing energetic conditions

Homeopathy Reconsidered: A factual book reappraises long-standing debate

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

Cultural practices improve health of Indigenous women recovering from trauma of partner violence

New apprenticeship scheme set to support Life Sciences Industrial Strategy of the UK government

New guidelines developed for effective management of neuropsychiatric symptoms of Huntington’s disease

E-cigarettes are almost twice as effective as nicotine replacement treatments, shows new study

Vaccination with live S. mitis may offer protection from Streptococcus pneumoniae

Computational model of the heart’s mitral valve enables customized care for patients

Expediting HPLC Method Development in Pharmaceutical Analysis

Corning Life Sciences to highlight advanced 3D cell culture technologies and tools at SLAS 2019

Having vaccine after shingles appear do not reduce the risk of stroke

Sleep, mood, and stress affect older adults' control beliefs

First precision medicine trial in lung cancer expands to include more patients

Researchers compare treatment options for fecal incontinence

Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News